Giant cell arteritis, also known as temporal
arteritis or cranial arteritis, is the most common MGC-linked disease. This type of arteritis causes the arteries in the head, neck, and arm area to swell to abnormal sizes. Although the cause of this disease is not currently known, it appears to be related to
polymyalgia rheumatica. Giant cell arteritis is most prevalent in older individuals, with the rate of disease being seen to increase from age 50. Women are 2–3 times more likely to develop the disease than men. Northern Europeans have been observed to have a higher incidence of giant cell arteritis compared to southern European, Hispanic, and Asian populations. It has been suggested that this difference may lie in the criteria used to diagnose giant cell arteritis rather than actual disease incidence, in addition to genetic and geographic factors.
Symptoms Symptoms may include a mild fever, loss of appetite, fatigue, vision loss, and severe headaches. These symptoms are often misinterpreted leading to a delay in treatment. If left untreated, this disease can result in permanent blindness.
Diagnosis The current highest standard for diagnosis is a
temporal artery biopsy. The skin on the patient's face is
anesthetized, and an incision is made in the face around the area of the temples to obtain a sample of the temporal artery. The incision is then sutured. A
histopathologist examines the sample under a microscope and issues a pathology report (pending extra tests that may be requested by the pathologist). The management regime consists primarily of systemic corticosteroids (e.g. prednisolone), commencing at a high dose. ==Langhans giant cell==